Image: Reuters
W.H.O Globalists Force Mismatched Experimental Ebola Jab on Congo – 70,000 Doses of Zaire-Only Vaccine Dumped into Bundibugyo Outbreak for “Trials” and Worker Control
The Democratic Republic of the Congo is about to be flooded with 70,000 doses of the Ervebo vaccine from the shadowy “global Ebola virus disease vaccine stockpile”, a product licensed solely against Zaire ebolavirus as the official response to a Bundibugyo virus outbreak.
Ervebo has zero proven efficacy against Bundibugyo. That has not stopped the WHO, CDC-aligned networks, and their Strategic Advisory Group of Experts on Immunization (SAGE) from green-lighting the deployment.
The shipment is split with clinical precision: 20,000 doses reserved for a Phase 3 trial to “study the impact” of this mismatched jab on Bundibugyo, and 50,000 more doses mandated for frontline and health workers under the latest SAGE recommendations.
This is not public health. This is the familiar playbook: an experimental product stockpiled for one pathogen is rapidly redirected into a different outbreak zone, rebranded as emergency response, and tested at scale on African populations while liability protections and data opacity remain firmly in place.
The same institutions that spent years expanding emergency powers, censorship, and injection mandates now treat Congo as the next testing ground all under the banner of “outbreak control.”
Get the latest news of our Loveworld News from our Johannesburg Stations and News Station South Africa, LN24International
Related Posts
Some description text for this item